Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

NCT05616663 | Unknown

• 1 other identifier: 7954
• Study Type: observational
• Target: 639
• Locations: 1 country
• Sites: 1

Brief Summary

Started on January 9, 2020 with the announcement of the discovery of a new SARS-CoV-2 coronavirus, the Covid-19 pandemic is responsible as of June 21, 2020 for 160,377 confirmed cases in France, 29,640 deaths and 9,823 hospitalizations. The Grand Est region is one of the regions in France that was most precociously and strongly affected by the epidemic, in particular the Strasbourg University Hospital. Faced with the heavy use of the healthcare system, hospital staff of all categories are an essential resource to be preserved. Several studies have shown the significant impact of Covid-19 on doctors and caregivers. In order to better protect these personnel and avoid contamination that could be harmful to their health but also because of the consequences in terms of staff, it is necessary to better understand the risk factors for transmission of this infection, the means of protection, the evolution of the disease and the determinants of the return to work. Few studies have explored on such a large workforce and in detail the professional risk factors for developing Covid-19 within different groups of hospital professionals including also non-caregivers and the evolution when returning to work in an outpatient population.

Conditions

COVID-19

Keywords

COVID-19; SARS-COV-2

Outcome Measures

Primary Outcomes (1)

• positive RT-PCR test

  The presence of SARS CoV 2 infection is assessed by a positive RT-PCR test

  one week after infection with Covid-19

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Professional rom the University Hospitals of Strasbourg (HUS) who had been working at the HUS at the time of the diagnosis of SARS CoV-2 infection.

You may qualify if:

• Major subject (≥18 years old)
• Professionals from the University Hospitals of Strasbourg (HUS)
• Professionals who had been working at the HUS at the time of the diagnosis of SARS CoV-2 infection.
• Subject having not expressed, after being informed, opposition to the reuse of their data for research purposes

You may not qualify if:

• \- Subject who expressed their opposition to participating in the study

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de Pathologie Professionnelle et Médecine du Travail - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Central Study Contacts

Maria GONZALEZ, MD, PhD

CONTACT

33 3 88 11 64 66; maria.gonzalez@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 14, 2022
• First Posted: November 15, 2022
• Study Start: July 31, 2020
• Primary Completion: December 16, 2023
• Study Completion: December 16, 2023
• Last Updated: December 8, 2023

Record last verified: 2023-12

Locations

FR (1)